Professor Peter K. Law was Invited to Participate in the "Wuhan International Cancer Precision Medical Summit"

2017/09/03

With the pressure of technological progress and medical expenses, precision medicine has received widespread attention from governments in the past two years, and is now experiencing unprecedented rapid development. On September 2, 2017 morning, (Wuhan) International Cancer Precision Medical Summit was held in Wuhan, Hubei grand. The summit is intended for all cancer treatment industry experts and scholars and medical personnel, including the Chinese Academy of Engineering, the famous respiratory disease expert Zhong Nanshan. Professor Peter K. Law, the Chairman and Chief Scientist of our Company, was also being invited to attend the meeting and gave a lecture entitled "Myoblast Transplantation Treatment". Professor Law's treatment technology has received extensive attention from experts. They all agreed that myoblast transplantation therapy technology targeted clearly, safe and effective, without any side effects, with broad prospects for development.

In addition, Professor Peter K. Law was hired as Wuhan University People's Hospital Cancer Center Distinguished Professor at the meeting, to assist the hospital to introduce myoblast transplantation therapy for the treatment of cancer, which opened a new chapter in cancer treatment.

In addition, Professor Peter K. Law was hired as Wuhan University People's Hospital Cancer Center Distinguished Professor at the meeting, to assist the hospital to introduce myoblast transplantation therapy for the treatment of cancer, which opened a new chapter in cancer treatment.